
Ep178: Peyton Greenside on ML-Guided Biologics Discovery
The Long Run with Luke Timmerman
00:00
The Future of Biologics Discovery
This chapter explores the flywheel effect in biologics discovery, highlighting how early successes can accelerate treatment development and reduce timelines. It also delves into the CEO's transition, team dynamics, and the biopharmaceutical company's strategic vision for innovative therapeutics leveraging AI and synthetic biology over the next decade.
Transcript
Play full episode